William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss advances in monkeypox testing, working with the CDC to scale testing and response efforts, the fast-spreading BA.5 variant of COVID-19, and how at-home testing affects the number of reported cases.
Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt Sause, president and CEO of Roche Diagnostics North America, explain how the well-intended Protecting Access to Medicare Act of 2014 (PAMA) puts vital diagnostic tests at risk.
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.
PACE - In this month’s “Virtual Lecture,” William Morice, M.D., Ph.D., gives an overview of the national response to the need for COVID-19 testing at the onset of, and during, the pandemic.
Dr. Morice talks about what lies ahead for laboratory medicine and how the opportunities and challenges in the field are intertwined.
Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its way.
Of five articles listed among the Journal of Clinical Microbiology’s “Top Cited” collection from the last two years, three included Mayo Clinic authors with papers focused on SARS-CoV-2.
As a regular contributor to Forbes regarding COVID-19, Dr. Matthew Binnicker offers expert health information to help people better understand the ever-changing nature of the pandemic.
On this week’s episode of the "Answers From the Lab" podcast, Bobbi Pritt, M.D., is joined by Matthew Binnicker, Ph.D., chair of Mayo Clinic’s Division of Clinical Microbiology. Dr. Pritt and Dr. Binnicker discuss the current state of laboratory testing for COVID-19 amid the omicron surge, as well the status of testing for other common respiratory viruses, including influenza.
Dr. William Morice II, president of Mayo Clinic Laboratories, named among the publication’s list of influencers, thought leaders, and key players driving change in the year ahead.
If you need a test for COVID-19, a variety of options are now available. But how do you know which one is right for you? Use this guide from Mayo Clinic Laboratories to sort through the choices and help you decide.
In this episode of “Lab Medicine Rounds” this holiday season, Justin Kreuter, M.D., and D. Jane Hata, Ph.D., D(ABMM), Assistant Professor of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, and Associate Director of the Clinical Microbiology Laboratory, including Molecular Virology, Mycology, and Parasitology at Mayo Clinic’s Florida campus, discuss responding with grace while under pressure.
With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.